<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: new drugs</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Scientists design experimental treatment for iron-overload diseases</title>
   	 <description>Iron overload is a common condition affecting millions of people worldwide. Excess iron in the body is toxic, and deposits can cause damage to the liver, heart and other organs. Current treatments, researchers say, are not ideal and have significant side effects.</description>
     <link>http://medicalxpress.com/news/2011-11-scientists-experimental-treatment-iron-overload-diseases.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 01 Nov 2011 12:44:12 EST</pubDate>
	 <guid isPermaLink="false">news239370231</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/14-scientistsde.jpg" width="90" height="90" />
</item>
<item>
     <title>ESC  Policy Conference makes recommendations for new EU medical device legislation</title>
   	 <description>The European Society of Cardiology (ESC) is calling for a single, co-ordinated European system to oversee the evaluation and approval of medical devices.   The call is being made in a paper published online in the  European Heart Journal  reporting on a conference  held by the ESC in January 2011 looking to increase the input of medical experts in developing medical device policy.</description>
     <link>http://medicalxpress.com/news/2011-05-esc-policy-conference-eu-medical.html</link>
	 <category>Other</category>
	 <pubDate>Mon, 16 May 2011 10:04:44 EST</pubDate>
	 <guid isPermaLink="false">news224759056</guid>
	 
</item>
<item>
     <title>How should systematic reviews consider evidence on harms?</title>
   	 <description>Systematic reviews that attempt to assess the risk of harms (adverse effects) associated with specific therapies should consider a broad range of study designs, including both systematic reviews and observational studies. These are the findings of a new study, led by Su Golder of the Centre for Reviews and Dissemination, University of York, UK published in this week's PLoS Medicine.</description>
     <link>http://medicalxpress.com/news/2011-05-systematic-evidence.html</link>
	 <category>Other</category>
	 <pubDate>Tue, 03 May 2011 17:41:49 EST</pubDate>
	 <guid isPermaLink="false">news223663296</guid>
	 
</item>
<item>
     <title>Many new drugs did not have comparative effectiveness information available at time of FDA approval</title>
   	 <description>Only about half of new drugs approved in the last decade had comparative effectiveness data available at the time of their approval by the U.S. Food and Drug Administration, and approximately two-thirds of new drugs had this information available when alternative treatment options existed, according to a study in the May 4 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2011-05-drugs-effectiveness-fda.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 03 May 2011 16:38:21 EST</pubDate>
	 <guid isPermaLink="false">news223659485</guid>
	 
</item>
<item>
     <title>Researchers join forces to cure deadly childhood disease</title>
   	 <description>The Center for World Health and Medicine at Saint Louis University and the Institute for OneWorld Health have established a joint research agreement to develop new drugs to combat diarrhea, which is the second leading cause of death worldwide in children under age 5.</description>
     <link>http://medicalxpress.com/news/2011-05-deadly-childhood-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 03 May 2011 10:49:33 EST</pubDate>
	 <guid isPermaLink="false">news223638555</guid>
	 
</item>
<item>
     <title>Researchers identify genes causing antimalarial drug resistance</title>
   	 <description>Using a pair of powerful genome-search techniques, researchers from the Harvard School of Public Health (HSPH), Harvard University, and the Broad Institute have identified several genes that may be implicated in the malaria parasite's notorious ability to rapidly evade drug treatments. Further testing revealed that one of the genes, when inserted into drug-sensitive parasites, rendered them less vulnerable to three antimalarial drugs.</description>
     <link>http://medicalxpress.com/news/2011-04-genes-antimalarial-drug-resistance.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 21 Apr 2011 17:21:55 EST</pubDate>
	 <guid isPermaLink="false">news222625303</guid>
	 
</item>
<item>
     <title>CMAJ calls on federal government to protect Canadians from unsafe drugs</title>
   	 <description>Canada needs to modernize its pharmaceutical drug laws to ensure that new drugs as well as older drugs are safe for Canadians, states an editorial in CMAJ (Canadian Medical Association Journal).</description>
     <link>http://medicalxpress.com/news/2011-04-cmaj-federal-canadians-unsafe-drugs.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 18 Apr 2011 16:07:13 EST</pubDate>
	 <guid isPermaLink="false">news222361601</guid>
	 
</item>
<item>
     <title>New study finds compounds show promise in blocking STAT3 signaling as treatment for osteosarcoma</title>
   	 <description>A study appearing in the journal Investigational New Drugs and conducted by researchers at Nationwide Children's Hospital, discovered that two new small molecule inhibitors are showing promise in blocking STAT3, a protein linked to the most common malignant bone tumor, osteosarcoma. These small molecule inhibitors &amp;#150; one derived from a portion of the turmeric spice &amp;#150; may serve as a new, non-toxic treatment for these deadly tumors.</description>
     <link>http://medicalxpress.com/news/2011-04-compounds-blocking-stat3-treatment-osteosarcoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 11 Apr 2011 15:51:27 EST</pubDate>
	 <guid isPermaLink="false">news221755865</guid>
	 
</item>


</channel>
</rss>
